AC Immune $117.5 million rights offering

26/7/2018

Rights issue

Value:

$ 117.5 million

Status:

Completed

Date:

26/7/2018

Overview:

Swiss biopharmaceutical company AC Immune issued two subscriptions rights offerings of 10 million new common shares raising $117.5 million.

Rajeeb Gurung - Researcher

Jurisdiction:

Switzerland

Deal type:

Rights issue

Practice area:

Capital markets : Equity

Industry sector:

Pharmaceuticals and life sciences

Firms:

Davis Polk & Wardwell

Party: AC Immune SA (Issuer)

VISCHER

Party: AC Immune SA (Issuer)

Lawyers: Matthias Staehelin, Stefan Grieder

Related deals